Radiotherapy for primary angiosarcoma of the breast: a case report

Open

Yoke Surpri Marlina, Rima Novirianthy, Teuku Muhammad Yus

2023 Bali Medical Journal Vol. 12 Issue 1 Article Cited by 0 SDG 3 Quartile

Abstract

Background: Primary breast angiosarcomas are very rare type malignant breast tumor. It may have an insidious clinical onset, presenting as a painless, often discrete palpable mass that grows rapidly. The ranged age of disease is 20-50 years. Case description: We report a case of a young woman with palpable and painless mass of her left breast. Based on radiological findings with mammography and MRI examination reported as malignant mass of the left breast suspected angiosarcoma. Pathological confirmation post-surgery reported a well-differentiated angiosarcoma that arose primarily in the left breast. Patient treated with simple mastectomy followed by whole breast radiotherapy. External beam radiotherapy delivered using 3DCRT with FIF technique, prescribed dose 60Gy in 30 fractions within 6 weeks. Conclusion: There is no established standard treatment for primary angiosarcoma of the breast. Mastectomy remains the mainstay of treatment. Adjuvant radiotherapy appears to improve local control. © 2023, Sanglah General Hospital. All rights reserved.

Affiliations

Department of Radiotherapy, Dr. Soetomo General Hospital, Surabaya, Indonesia; Department of Radiology, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia

Research at a Glance

Premium content — register to unlock

Research at a Glance

Register to unlock

Topics & SDG Alignment

Premium content — register to unlock

Topics & SDG Alignment

Register to unlock

Collaboration

Premium content — register to unlock

Collaboration

Register to unlock

Author Profile (Selected)

Premium content — register to unlock

Author Profile (Selected)

Register to unlock

References Overview

Premium content — register to unlock

References Overview

Register to unlock

Journal & Source

Premium content — register to unlock

Journal & Source

Register to unlock

Metadata & Integrity

Premium content — register to unlock

Metadata & Integrity

Register to unlock